Efficacy and safety of low‐dose apatinib in ovarian cancer patients with platinum‐resistance or platinum‐refractoriness: A single‐center retrospective study
Abstract Background This study aimed to evaluate the efficacy and safety of apatinib with a low dose of 250 mg/d in the treatment of platinum‐resistant or platinum‐refractory ovarian cancer patients. Methods Patients with platinum‐resistant or platinum‐refractory ovarian carcinoma treated with 250 m...
Guardat en:
| Autors principals: | , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Wiley
2020-08-01
|
| Col·lecció: | Cancer Medicine |
| Matèries: | |
| Accés en línia: | https://doi.org/10.1002/cam4.3282 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|